Invoicing & Payment,
Spend Analysis & Benchmarking,
Supplier Relationship Management,
B2B Social Media: Online Supply Communities, Open Innovation, SM B2B Marketing, SM Customer Driven Support
Industry Groups: Construction, Defence & Aerospace, Education, Financial Services, Healthcare, Manufacturing & Automotive, Public Sector, Resources, Retail & CPG/FMCG, Utilities
Categories / Commodities: Business Travel, Capital Equipment, Construction & Building, Electronic & High Tech, Fuels & Lubricants, Managed Print Services, Marketing & Advertising, Metals & Minerals, Office Suppliers, Services Procurement, Supply Chain Management, Transport & Logistics
Procurement People: Careers, Leadership, People on the move, Talent Management
Articles in category: Healthcare
In 2015, a primary focus should be on data. That’s the key to unlocking the supply chain challenges facing the industry.
The supply chain trends we’ve seen over the past couple years will continue including provider and supplier consolidation, patient care moving outside the acute care setting, reduced reimbursement levels, implementation of and integration with electronic health records (EHRs) and other healthcare business systems.
Medical procurement can be a complex, multifaceted endeavor with many options and factors to consider. One area to think about is delivery: you need to know where your products will be sent and how they will be setup and installed once they are received at your building. In order to get the best sense of how your hospital or medical facility should handle this aspect of procurement, consider the results from a recent direct-to-site delivery study conducted by Hospital Associates.(Read Full Article)
JSE-LISTED pharmaceutical company Adcock Ingram has emerged as the clear loser among the domestic drug manufacturers after it won a mere R700m of the government’s R14bn HIV/AIDS drug tender, say analysts.
It got no part of the key contract to supply fixed-dose combination (FDC) pills, which form the core of the government’s treatment programme.(Read Full Article)
Pretoria - The national Department of Health has announced various pharmaceutical companies that won the three year tender to supply antiretroviral (ARVs) to millions of patients on treatment in South Africa.
The Southern African Development Community (SADC) can learn from the difficulties faced by the Economic Community of West African States (ECOWAS) in curtailing the spread of Ebola. The Ebola epidemic has highlighted the need for regional access to medicines in West Africa.
The capacity to regulate this sector in SADC faces a number of challenges. There is limited scope for growth of a local pharmaceutical production sector, considering India's dominance of generic manufacturing. African industries are challenged by the presence of imported generics. Indian pharmaceuticals are subsidised and are cheaper to import.(Read Full Article)
South Africa plans to spend $2.2-billion over two years to buy HIV/AIDS drugs for public hospitals, a government minister said on Monday, as a study shows the prevalence of the virus is rising.
Speaking at a manufacturing plant of drugmaker Aspen Pharmacare, Trade and Industry Minister Rob Davies said the government aims to buy three quarters of the drugs from local manufacturers.(Read Full Article)
Global hotel chain Marriott International expects strong long-term demand growth in the domestic tourism and hospitality sector(Read Full Article)
Spend Matters welcomes another guest post from Ivy Montgomery of Vroozi. This is an ongoing series of posts providing real-life use cases of mobile procurement.
The benefits of adopting a mobile procurement strategy extend far beyond the walls of the procurement department. Indeed, the real value of mobility in the procurement process is that it enables all employees to do their jobs in the most efficient way possible – including CPOs, purchasing managers, and yes, even nurses.(Read Full Article)
DRUG maker GlaxoSmithKline (GSK) plans to invest up to £130m in Africa over the next five years as it bets on the importance of the continent in driving long-term demand for medicine.
The decision reflects the pharmaceutical industry’s growing interest in Africa, given improved economic growth and rising demand for treatments against chronic diseases that are becoming more common among urban middle classes. France’s Sanofi has also highlighted Africa as a promising growth market.(Read Full Article)
A supplier of generic medicines in Cape Town says pharmaceutical companies’ objections to draft legislation to amend patent laws boils down to their fearing losing their monopoly.
Cape Town - A supplier of generic medicines in Cape Town says pharmaceutical companies’ objections to draft legislation to amend patent laws boils down to their fearing losing their monopoly.(Read Full Article)
Johannesburg - A state-owned pharmaceutical company would be the best way to keep the costs of medication down, the National Education Health and Allied Workers Union (Nehawu) said on Monday.
Spokesman Sizwe Pamla said in a statement that privately-owned drug companies were motivated by profit rather than the well-being of those who rely on their medications. “We should also remember that these people make their money from commodifying and prolonging sickness and not from curing it"(Read Full Article)
Pretoria – The Gauteng Department of Health has invested R30 million towards brand new linen for hospitals and clinics currently facing acute shortages. Gauteng Health spokesperson Simon Zwane said the department has over the past year faced an acute shortage of linen, including bed linen, doctors’ linen for theatre use, patient clothing and other protective clothing control linen.
As part of addressing the crisis, the department has started the Gauteng Provincial Government linen bank. “The department moved to urgently invest just up to R30 million in linen procurement from various providers, including women's cooperatives, the Department of Labour and other ...
Low salaries and skimpy budgets drive doctors, nurses and administrators to make ends meet by accepting money from patients, drug suppliers and others. Accusations last month that GlaxoSmithKline employees bribed Chinese doctors to prescribe its drugs brought international attention to the flow of illicit money. But to China's public, the practice has long been common knowledge. Many blame a system in which the country's hospitals nearly all are state-run but get too little money from Beijing. Most of China's 2.3 million doctors are hospital employees and are barred from adding to their income by taking on ...(Read Full Article)
The expiry of patent revenues and corruption in hugely important markets head a raft of challenges that pharma needs to address - and procurement will have a key role to play. Inferences abound about China’s recent crackdown on bribery by GSK officials who acted independently of their employer. It may well be indicative of the causes of the country’s recent banking scare. If you missed the scare, it’s because it didn’t last long since China’s central bank, only briefly, refused to play its role as lender of last resort at the end of H1 when it ...(Read Full Article)
The wellbeing of women in developing countries will receive a boost following a deal between the World Bank and the United Nations to simplify procurement of sexual health supplies. Under the arrangement, World Bank borrowers can purchase reproductive health supplies directly from the United Nations Population Fund (UNFPA) without needing to use World Bank-specific ordering, invoicing and payment systems. Orders will instead be placed with the UNFPA, which receives the funds directly to commence procurement. The new arrangement cuts red tape, saving time and money, and helps governments access quality and competitively-priced sexual health products.(Read Full Article)
GlaxoSmithKline (GSK) has launched a review into all of its previous transactions with travel agencies in China, following the arrest of a number of its executives over allegations of bribery. It follows a disclosure from the Chinese police, which believes multiple senior figures at the firm used travel agents as intermediaries to channel payments to medical professionals. The police, which described the offences as “serious economic crimes”, suspect the payments were used to get medical professionals to buy GSK products. In response to the allegations, a spokesman for GSK said: “We are deeply concerned and disappointed by these serious allegations ...(Read Full Article)
Attracting talent to help the function move forward means persuading bright young things why procurement is a good career option. In this guest blog, Procurement Leaders invites former GlaxoSmithKline procurement director Jan Piskadlo to develop a discussion on starting a career in procurement that first appeared on the People In Procurement LinkedIn group. As sure as night follows day, there will always be a standing agenda item at conferences and roundtables on Procurement talent (or more likely lack of) and why the function consistently struggles to attract the right DNA. I believe the answer can be found in the old ...(Read Full Article)
Johannesburg - Adcock Ingram Holdings, South Africa’s largest supplier of hospital products, may gain a further 12 percent from yesterday’s 30-month high after it got takeover offers, according to JPMorgan Chase. Adcock’s board has received non-binding proposals that could lead to an offer for the whole company or a controlling stake, the Johannesburg-based maker of Panado painkillers and Corenza cold medicine said yesterday. The stock rose 8.9 percent to 67.50 rand by the close in Johannesburg, its highest level since November 2010, valuing the company at $1.3 billion.(Read Full Article)
The takeover battle between Bidvest and Adcock Ingram is turning into a ding-dong affair, and like many tough takeover battles, it is exposing an interesting and important part of takeover law. Just to recap a bit, here is what has happened so far. Bidvest, the widely diversified industrial group, sent Adcock, a pharmaceutical provider, a takeover proposal to acquire 60% of the company.......(Read Full Article)
For pharmaceutical firms, Africa is changing. Not only is the continent’s economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma. Opportunities are opening up for treating chronic diseases afflicting the middle classes, rather than just firefighting infection. European firms in particular hope to reap rewards by investing early in a region where many of them already have historic commercial ties.(Read Full Article)
The merger between the largest and third-largest companies in the South African infant milk formula market, Nestlé and Pfizer Nutrition, has been approved by the Competition Tribunal, but with a detailed list of conditions to alleviate concerns about lessening of competition and potential price increases. The tribunal found, in its investigation into the effect of the global transaction on the South African market, that Aspen was the only other major company in the country and that the merger would leave only two competitors in the market, increasing the likelihood of price increases.
British newspaper, The Daily Telegraph, uncovered that GSK has begun extending its payment terms from 60 days at the end of last year to 90 days, a move which Phil Orford, chief executive of the Forum of Private Business said shows ’scant regard’ for small suppliers. One GSK supplier who spoke to The Daily Telegraph anonymously said: "This kind of borrowing from suppliers – whatever their size – is scandalous."(Read Full Article)
South African drugmakers are the big winners in a $667 million contract to supply HIV drugs awarded this week by the government of Africa's largest economy, with three local companies taking nearly 60 percent of the deal. South Africa on Thursday awarded the two-year contract to 12 domestic and international firms to supply life-prolonging drugs to treat its biggest single health problem. Aspen Pharmacare, Africa's largest generic drugs maker, has won 20.6 percent of the contract, while smaller rival Adcock Ingram was awarded 14 percent, the health department said in a statement.(Read Full Article)
I suspect that Ben Goldacre's 'Bad Pharma' would not immediately come to mind as a recommended procurement read. Let me correct that misconception. While the book is primarily about the pharmaceutical industry, it has a sub-plot of market manipulation of buyers. It highlights how sales-forces, conferences, professional bodies, advertisements, magazine articles, and even academic journals are used to manipulate, within strategic marketing plans, to deliver sales. It is a book which should be read by every procurement manager, regardless of industry.(Read Full Article)